Schedule Appointment
Schedule Appointment
What is the cost of Spravato treatment and how is it covered by insurance? Spravato (esketamine) is an FDA-approved nasal spray for treatment-resistant depression (TRD) whose cost involves medication fees, clinical administration, and monitoring. Many patients experience its benefits within hours to days under professional supervision, and insurance coverage varies widely among private insurers, Medicare, and Medicaid. Next Step Psychiatry is committed to helping you navigate these costs and financial assistance options, so treatment is affordable and accessible.
Spravato treatment entails several cost components. The expense is not limited to the medication itself but also includes fees for clinical administration and required monitoring post-administration.
| Cost Component | Average Price Range |
|---|---|
| Medication (per dose) | $700 - $1,200 |
| Administration & Monitoring | $200 - $300 per session |
| Initial Evaluation | $250 - $400 |
In comparison to other treatment-resistant depression (TRD) therapies—such as Transcranial Magnetic Stimulation (TMS) or Electroconvulsive Therapy (ECT)—Spravato offers a less invasive method with rapid onset of effects, though upfront costs may be higher.
| Program | Typical Coverage |
|---|---|
| Medicare Part B | Approximately 80% (after deductible) |
| Medicaid | Varies by state; often case-by-case approval |
For detailed guidance, check with your plan and utilize our psychiatric evaluation page to understand eligibility for Spravato coverage.
Some treatment centers offer flexible payment plans allowing you to spread the cost over several months. While Janssen does not directly offer sliding scale options, many independent clinics do provide income-based discounts. Contact us for personalized financial counseling.
| Session Frequency | Monthly Cost Range |
|---|---|
| Weekly | $2,500 - $3,750 |
| Biweekly | $1,200 - $1,800 |
As treatment continues, the frequency of sessions may be reduced if patients achieve symptom improvement, thereby lowering the ongoing monthly cost.
In addition to cost, it is important to understand the treatment timeline, the signs that Spravato is effective, and the differences in available formulations. Patients should have realistic expectations regarding both the financial investment and the trajectory of symptom improvement.
Spravato is available in two primary dosages: 56 mg and 84 mg. These formulations are administered via a nasal spray under strict medical supervision due to potential side effects (such as dissociation and increased blood pressure) that require a dedicated post-dose monitoring period.
| Dosage | Usage Phase | Typical Administration Frequency |
|---|---|---|
| 56 mg | Initial Induction | Twice weekly |
| 84 mg | Maintenance & Dose Optimization | Weekly or Biweekly |
At Next Step Psychiatry, we understand that both mental health care and financial concerns are paramount. Our team is dedicated to:
For additional information on our services, visit our Services and Contact pages.
Without insurance, a single dose of Spravato can cost between $700 and $1,200, plus additional fees for administration and monitoring.
Yes, Medicare Part B usually covers Spravato treatment for eligible patients, covering approximately 80% of costs after deductibles, with prior authorization required.
Patients can enroll in manufacturer savings programs like the SPRAVATO withMe Savings Program, use observation rebate programs, and explore flexible payment plans offered by many treatment centers.
At Next Step Psychiatry, we’re committed to making Spravato treatment accessible and affordable. Let our team help you navigate insurance verification, financial assistance, and flexible payment options so you can focus on your recovery.
Schedule Your Consultation: